Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating HRG2010 for Parkinson's disease with motor fluctuations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• HRG2010

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED